Quarterly report pursuant to Section 13 or 15(d)

Warrants and Derivative Liabilities (Detail Textuals)

v3.19.1
Warrants and Derivative Liabilities (Detail Textuals) - USD ($)
 1 Months Ended 3 Months Ended
Feb. 28, 2018
Jan. 19, 2018
Mar. 31, 2019
Mar. 31, 2018
Feb. 16, 2018
Class of Warrant or Right [Line Items]          
Warrants Issued In Connection With Convertible Multi Draw Credit Agreement Related Party Value     $ 716,110    
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model     12,820,618 $ (977,493)  
Issuance costs related to warrant liability       $ 137,191  
Warrant          
Class of Warrant or Right [Line Items]          
Warrants Issued In Connection With Convertible Multi Draw Credit Agreement Related Party Value     $ 716,110    
Warrant | Emerald Health Sciences Inc          
Class of Warrant or Right [Line Items]          
Number of warrants issued 3,400,000 40,800,000 5,000,000    
Total number of warrants issued 44,200,000 44,200,000      
Warrant exercise price $ 0.10 $ 0.10      
Term of warrant 5 years 5 years      
Warrants Issued In Connection With Convertible Multi Draw Credit Agreement Related Party Value     $ 716,110    
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model     $ 1,830,573    
Emerald Warrant Liabilities          
Class of Warrant or Right [Line Items]          
Value of common stock called by warrants   $ 4,700,000     $ 5,700,000